Celcuity Inc.’s CEO, Brian Sullivan, to Present at Two Upcoming Investor Conferences
Minneapolis, MN, February 25, 2025 – Celcuity Inc. (CELC), a pioneering biotechnology company dedicated to the development of targeted therapies for oncology, has announced that its Chief Executive Officer and Co-founder, Brian Sullivan, will participate in two upcoming investor conferences:
1. 34th Annual J.P. Morgan Healthcare Conference
Brian Sullivan will present an update on Celcuity’s business and development progress at the 34th Annual J.P. Morgan Healthcare Conference, which will be held in San Francisco, California, from January 9-13, 2026. The presentation is scheduled for Tuesday, January 10, 2026, at 1:30 p.m. Pacific Time in the Grand Ballroom of the Westin St. Francis Hotel.
2. 16th Annual Needham Healthcare Conference
Additionally, Sullivan will be available for one-on-one investor meetings at the 16th Annual Needham Healthcare Conference, taking place in New York City, New York, on March 1-2, 2026. Investors interested in scheduling a meeting with Brian Sullivan should contact the Needham conference coordinators.
These investor conferences provide an excellent opportunity for Celcuity to engage with the investment community, discuss its ongoing clinical trials, and showcase its innovative approach to developing targeted therapies for oncology. The presentations and meetings will offer valuable insights into the company’s progress, potential collaborations, and future plans.
Impact on Individuals
For individuals following Celcuity’s progress or considering investing in the company, these investor conferences offer an excellent opportunity to learn more about the company’s latest developments and ask questions directly to the CEO. By attending these conferences or following post-event coverage, investors can gain a better understanding of Celcuity’s business and potential growth opportunities.
Impact on the World
On a larger scale, Celcuity’s presentations and meetings at these investor conferences could attract the attention of potential partners, investors, and collaborators. This increased visibility could lead to new opportunities for the company, ultimately contributing to the advancement of targeted therapies for oncology and improving patient outcomes.
Conclusion
Celcuity Inc.’s participation in the 34th Annual J.P. Morgan Healthcare Conference and the 16th Annual Needham Healthcare Conference marks an exciting time for the company as it continues to develop targeted therapies for oncology. These investor conferences offer valuable opportunities for Celcuity to engage with the investment community, showcase its progress, and explore new collaborations. For individuals following the company or considering investing, these events provide an excellent opportunity to learn more about Celcuity’s latest developments and ask questions directly to the CEO. Ultimately, the presentations and meetings could lead to new opportunities for Celcuity, contributing to the advancement of targeted therapies for oncology and improving patient outcomes worldwide.
- Celcuity Inc.’s CEO, Brian Sullivan, to present at the 34th Annual J.P. Morgan Healthcare Conference and the 16th Annual Needham Healthcare Conference
- Presentations and meetings offer valuable opportunities for Celcuity to engage with the investment community and explore new collaborations
- Individuals following Celcuity or considering investing can learn more about the company’s latest developments and ask questions directly to the CEO
- These events could lead to new opportunities for Celcuity, contributing to the advancement of targeted therapies for oncology and improving patient outcomes
